| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 27.065 | 54.448 | 65.744 | 79.750 |
| Total Income - EUR | - | - | - | - | - | - | 27.065 | 54.448 | 65.744 | 79.750 |
| Total Expenses - EUR | - | - | - | - | - | - | 396 | 2.768 | 9.595 | 10.604 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 26.669 | 51.680 | 56.149 | 69.147 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 25.873 | 50.345 | 55.505 | 66.802 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Teocardiomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 37.590 | 62.359 | 69.275 | 68.117 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 25.892 | 54.714 | 58.371 | 54.061 |
| Cash | - | - | - | - | - | - | 11.698 | 7.645 | 10.904 | 14.056 |
| Shareholders Funds | - | - | - | - | - | - | 25.873 | 50.345 | 55.505 | 66.802 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | 11.717 | 12.014 | 13.771 | 1.314 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Teocardiomed S.r.l.